MEF2B is a potent transactivator expressed in early myogenic lineages

Jeffery D. Molkentin, Anthony B. Firulli, Brian L. Black, James F. Martin, Carolyn M. Hustad, Neal Copeland, Nancy Jenkins, Gary Lyons, Eric N. Olson

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'MEF2B is a potent transactivator expressed in early myogenic lineages'. Together they form a unique fingerprint.

Medicine & Life Sciences